Research against the corona virus

The Fraunhofer ISC with its Translational Center for Regenerative Therapies is working together with virologists from the University of Würzburg to combat the virus: with rapid tests of potential active substances against SARS-CoV-2.

more info

Lab Automation and Bioreactor Technologies

The incubator and bioreactor systems developed at TLC-RT have a modular structure and can be adjusted to a wide variety of culture conditions.

more info

Biomaterials

The TLC-RT develops synthetic as well as bio-logically based materials, e. g. (μ- and nano-) particles, fibers, coatings for regenerative medicine, tissue engineering and diagnostics. One of the core tasks is to cover the entire value chain, starting from R&D-tasks over process up-scaling, pre-clinic evaluation to the clinical phases.

more info

Clinical Development

The production of novel drugs and medical devices is subject to high quality requirements. By fulfilling current regulatory guidelines, the TLC-RT ensures the highest level of patient safety for these new, innovative therapies.

more info

Test Systems and 3D Tissue Models

3D tissue models includes model systems of healthy and diseased organs to study pathogenic mechanisms and to test and evaluate new drugs. Picture shows a full skin model.

more info

Fraunhofer Translational Center Regenerative Therapies TLC-RT

more info

Fraunhofer Translational Center Regenerative Therapies TLC-RT

The Fraunhofer Translational Center Regenerative Therapies TLC-RT develops new cell based tissue models and test systems, scalable manufacture processes, prototypes and biological vascularized implants. Therefore, besides accelerating cost efficient drug development, TLC-RT contributes to promoting the 3R principles.

Read more ...

 

Press Release / 19.11.2020

Project launch »ImAi«

New test procedure to replace worldwide standard animal testing - project launched

 

Research against the corona virus

Tissue models for rapid drug testing

 

Partner for EU projects

Fraunhofer ISC has an excellent record of accomplishments in European collaboration and can build on a large international network of research partners from industry as well as research.

Fields of Activity and Teaching

 

Biomaterials

  • Regenerative Biomaterials
  • In vitro and in vivo diagnostics
  • Drug Delivery
  • Future Technologies
 

Lab Automation and Bioreactor Technologies

 

In vitro Testsystems

  • Standardized in vitro test systems
  • Disease models
  • hiPSC technologies
 

Preclinical and Clinical Development

  • Implants / GMP
  • Preclinical / GLP
 

Chair of Tissue
Engineering and
Regenerative Medicine

  • Development of supporting structures
  • Cell culture techniques
 

Contact or callback?

 

Contact us today without any
obligation!

 

Project TheraVision – Innovative therapy against cancer

In the "TheraVision" project, five Fraunhofer Institutes have set themselves the goal of establishing a widely applicable platform technology for an innovative, sustainable cancer therapy that combines cancer-killing viruses and immunotherapy. The activation of the immune system against the degenerated tumor cells is a novel promising therapeutic approach.

News and Events

19.11.2020

New test procedure to replace worldwide standard animal testing - project launched

The ImAi project, funded by the Federal Ministry of Education and Research, is intended to create an animal-free replacement for the Draize test on rabbits used worldwide to assess the eye irritancy potential of chemicals. The new test is based on tissue models of the cornea cultivated in the laboratory. At the end of the project, a new standard procedure should be available for use worldwide.
Read more

26.10.2020

Fraunhofer Solution Days

As part of the project “Go Beyond 4.0”, Fraunhofer ISC is participating in the digital Fraunhofer event, the Solution Days, on October 26, 2020. You can look forward to the latest technology highlights, workshops and live chats with our experts. We are looking forward to your visit on our digital booth.
Read more

25.8.2020

Fraunhofer relies on Automation Technologies in Medical Research

As a pioneer in applied research, the Fraunhofer-Gesellschaft brings together the expertise of 23 separate Fraunhofer facilities to develop new development and production technologies for innovative cell and gene therapeutics, as well as vaccines, in the “Production for Intelligent Medicine” innovation cluster. As a first step of the project, a concept for a modular pilot plant for the automatic production of these therapeutics is to be developed combining both Industry 4.0 and Health 4.0.
Read more

8.4.2020

Research against the corona virus -
tissue models for rapid drug testing

The pandemic caused by SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) is placing unprecedented restrictions on public life and economy. The global research efforts to fill the knowledge gaps regarding the new pathogen and to develop effective therapies are correspondingly large. In Wuerzburg, too, researchers from the Fraunhofer Translational Center for Regenerative Therapies are working together with the virologist Prof. Dr. Bodem from the University of Wuerzburg to identify active substances against the virus.
Read more
 

Project APRONA

Flexible robot-based platform for automated production of nanoparticles.

Your local contact

Marco Metzger

Contact Press / Media

PD Dr. Marco Metzger

Director TLC-RT

Fraunhofer Translational Center Regenerative Therapies TLC-RT
Röntgenring 11
97070 Würzburg, Germany

Phone +49 931 3186686

Oliver Pullig

Contact Press / Media

PD Dr. Oliver Pullig

Deputy Director of TLC-RT / Head of Clinical Development

Translational Center Regenerative Therapies TLC-RT
Röntgenring 11
97070 Würzburg, Germany

Phone +49 931 31-83748